Search research articles
Contact Us
Filters
Showing results (11-20 of 22) with videos related to
Page
of 3
Sort By:
Frontiers in Immunology
|
September 8, 2025
A phase II randomized trial of individualized neoantigen peptide vaccine combined with unusual radiotherapy (iNATURE) in advanced solid tumors-GCOG0028
Yan Zhang, Ye-Fan Hu, Lingyu Ma, et al.
Frontiers in Immunology
|
April 11, 2022
Computation of Antigenicity Predicts SARS-CoV-2 Vaccine Breakthrough Variants
Ye-Fan Hu, Jing-Chu Hu, Hua-Rui Gong, et al.
Cell Research
|
August 6, 2020
SARS-CoV-2 infects human neural progenitor cells and brain organoids
Bao-Zhong Zhang, Hin Chu, Shuo Han, et al.
Cell Research
|
July 3, 2020
Mining of epitopes on spike protein of SARS-CoV-2 from COVID-19 patients
Bao-Zhong Zhang, Ye-Fan Hu, Lin-Lei Chen, et al.
Cell Host & Microbe
|
August 1, 2023
Rational design of a booster vaccine against COVID-19 based on antigenic distance
Ye-Fan Hu, Terrence Tsz-Tai Yuen, Hua-Rui Gong, et al.
JCI Insight
|
April 21, 2022
Bacillus Calmette-Guérin-induced trained immunity protects against SARS-CoV-2 challenge in K18-hACE2 mice
Bao-Zhong Zhang, Huiping Shuai, Hua-Rui Gong, et al.
Emerging Microbes & Infections
|
April 23, 2021
A novel linker-immunodominant site (LIS) vaccine targeting the SARS-CoV-2 spike protein protects against severe COVID-19 in Syrian hamsters
Bao-Zhong Zhang, Xiaolei Wang, Shuofeng Yuan, et al.
Ebiomedicine
|
December 15, 2023
Divergent trajectory of replication and intrinsic pathogenicity of SARS-CoV-2 Omicron post-BA.2/5 subvariants in the upper and lower respiratory tract
Bingjie Hu, Jasper Fuk-Woo Chan, Yuanchen Liu, et al.
Ebiomedicine
|
August 14, 2023
The viral fitness and intrinsic pathogenicity of dominant SARS-CoV-2 Omicron sublineages BA.1, BA.2, and BA.5
Huiping Shuai, Jasper Fuk-Woo Chan, Bingjie Hu, et al.
Ebiomedicine
|
October 24, 2021
Emerging SARS-CoV-2 variants expand species tropism to murines
Huiping Shuai, Jasper Fuk-Woo Chan, Terrence Tsz-Tai Yuen, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 22) with videos related to
Sort By:
Page
of 3
Frontiers in Immunology
|
September 8, 2025
A phase II randomized trial of individualized neoantigen peptide vaccine combined with unusual radiotherapy (iNATURE) in advanced solid tumors-GCOG0028
Yan Zhang, Ye-Fan Hu, Lingyu Ma, et al.
Frontiers in Immunology
|
April 11, 2022
Computation of Antigenicity Predicts SARS-CoV-2 Vaccine Breakthrough Variants
Ye-Fan Hu, Jing-Chu Hu, Hua-Rui Gong, et al.
Cell Research
|
August 6, 2020
SARS-CoV-2 infects human neural progenitor cells and brain organoids
Bao-Zhong Zhang, Hin Chu, Shuo Han, et al.
Cell Research
|
July 3, 2020
Mining of epitopes on spike protein of SARS-CoV-2 from COVID-19 patients
Bao-Zhong Zhang, Ye-Fan Hu, Lin-Lei Chen, et al.
Cell Host & Microbe
|
August 1, 2023
Rational design of a booster vaccine against COVID-19 based on antigenic distance
Ye-Fan Hu, Terrence Tsz-Tai Yuen, Hua-Rui Gong, et al.
JCI Insight
|
April 21, 2022
Bacillus Calmette-Guérin-induced trained immunity protects against SARS-CoV-2 challenge in K18-hACE2 mice
Bao-Zhong Zhang, Huiping Shuai, Hua-Rui Gong, et al.
Emerging Microbes & Infections
|
April 23, 2021
A novel linker-immunodominant site (LIS) vaccine targeting the SARS-CoV-2 spike protein protects against severe COVID-19 in Syrian hamsters
Bao-Zhong Zhang, Xiaolei Wang, Shuofeng Yuan, et al.
Ebiomedicine
|
December 15, 2023
Divergent trajectory of replication and intrinsic pathogenicity of SARS-CoV-2 Omicron post-BA.2/5 subvariants in the upper and lower respiratory tract
Bingjie Hu, Jasper Fuk-Woo Chan, Yuanchen Liu, et al.
Ebiomedicine
|
August 14, 2023
The viral fitness and intrinsic pathogenicity of dominant SARS-CoV-2 Omicron sublineages BA.1, BA.2, and BA.5
Huiping Shuai, Jasper Fuk-Woo Chan, Bingjie Hu, et al.
Ebiomedicine
|
October 24, 2021
Emerging SARS-CoV-2 variants expand species tropism to murines
Huiping Shuai, Jasper Fuk-Woo Chan, Terrence Tsz-Tai Yuen, et al.
Page
of 3